Activated platelet and oxidized LDL induce endothelial membrane vesiculation: Clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes

被引:67
作者
Nomura, S
Shouzu, A
Omoto, S
Nishikawa, M
Iwasaka, T
Fukuhara, S
机构
[1] Kansai Med Univ, Dept Internal Med 1, Moriguchi, Osaka 5708507, Japan
[2] Kansai Med Univ, Dept Internal Med 2, Moriguchi, Osaka 5708507, Japan
关键词
endothelial cell-derived microparticle; P-selectin; type 2 diabetes mellitus; CD40; ligand; anti-oxidized LDL antibody;
D O I
10.1177/107602960401000302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelial cells, platelets, and oxidized LDL could play very important roles in the development of atherosclerosis in diabetes patients. The levels of plasma endothelial cell-derived microparticles (EDMP), platelet-derived microparticles (PDMP), platelet-P-selectin (plt-PS), soluble CD40 ligand (sCD40L), and anti-oxidized LDL antibody were measured and compared to develop a better understanding of their potential contribution to diabetic vascular complications. The concentrations of EDMP, PDMP, plt-PS, and sCD40L in diabetic patients were significantly higher than those in normal subjects. The number of EDMPs in patients with diabetes complicated by nephropathy was significantly higher than that in those without complications. Levels of anti-oxidized LDL antibody were also higher in type 2 diabetic patients than in control subjects. In addition, anti-oxidized LDL antibody levels correlated with EDMP, PDMP, plt-PS, and sCD40L levels in nephropathy patients. In the nephropathy group treated with sarpogrelate hydrochrolide, a 5-HT2A receptor antagonist, EDMP, PDMP, plt-PS, and sCD40L levels were decreased significantly. Oxidized LDL increased expression of plt-PS, and also promoted shedding of PDMP. Furthermore, oxidized LDL promoted a dose-dependent release of 5-hydroxytriptamine. On the other hand, activated platelets and PDMP promoted endothelial cells and THP-1 (monocytic cell line) interaction, and membrane vesiculation occurred in the presence of oxidized LDL. These findings suggest that activated platelets and oxidized LDL induce EDMP generation, and that elevated EDMPs may be a sign of vascular complications in type 2 diabetic patients, particularly those who suffer from diabetes-associated nephropathy.
引用
收藏
页码:205 / 215
页数:11
相关论文
共 56 条
[1]   PLATELET ACTIVATION BY OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS [J].
ARDLIE, NG ;
SELLEY, ML ;
SIMONS, LA .
ATHEROSCLEROSIS, 1989, 76 (2-3) :117-124
[2]  
BAUMGARTNERPARZER SM, 1995, DIABETOLOGIA, V38, P1367
[3]   MONOCYTE ADHERENCE TO HUMAN VASCULAR ENDOTHELIUM [J].
BEEKHUIZEN, H ;
VANFURTH, R .
JOURNAL OF LEUKOCYTE BIOLOGY, 1993, 54 (04) :363-378
[4]   AUTOANTIBODIES AGAINST OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS IN NIDDM [J].
BELLOMO, G ;
MAGGI, E ;
POLI, M ;
AGOSTA, FG ;
BOLLATI, P ;
FINARDI, G .
DIABETES, 1995, 44 (01) :60-66
[5]  
BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003
[6]   PROTEINURIA - VALUE AS PREDICTOR OF CARDIOVASCULAR MORTALITY IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BORCHJOHNSEN, K ;
KREINER, S .
BMJ-BRITISH MEDICAL JOURNAL, 1987, 294 (6588) :1651-1654
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   SINGLE RISK FACTOR INTERVENTION MAY BE INADEQUATE TO INHIBIT ATHEROSCLEROSIS PROGRESSION WHEN HYPERTENSION AND HYPERCHOLESTEROLEMIA COEXIST [J].
CHOBANIAN, AV .
HYPERTENSION, 1991, 18 (02) :130-131
[9]   In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant [J].
Combes, V ;
Simon, AC ;
Grau, GE ;
Arnoux, D ;
Camoin, L ;
Sabatier, F ;
Mutin, M ;
Sanmarco, M ;
Sampol, J ;
Dignat-George, F .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (01) :93-102
[10]   E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: Possible role of oxidative stress [J].
Cominacini, L ;
Fratta Pasini, A ;
Garbin, U ;
Campagnola, M ;
Davoli, A ;
Rigoni, A ;
Zenti, MG ;
Pastorino, AM ;
LoCascio, V .
DIABETOLOGIA, 1997, 40 (05) :584-589